Table 6.
Author | Patients | N | Regimen | OOR (%) | Median PFS | Median OS |
---|---|---|---|---|---|---|
Shimada M [48] | Stage I-IV | 24 | Platinum based regimen | 12.5 | NA | NA |
Hess V [74] | Stage III/IV | 19 | Platinum based regimen | 26.3 | 5.7 | 12.0 |
Bamias A [75] | Stage III/IV | 24 | Paclitaxel/platinum | 45.0 | NA | 15.4 |
Pectasides D [76] | Stage III/IV | 47 | Platinum based regimen | 38.5 | 11.8 (TTP) | 33.2 |
Pisano C [77] | Stage I-IV | 19 | Platinum based regimen | 42.1 | NA | NA |
Abbreviations: ORR, Objective response rate; PFS, Progression-free survival; OS, Overall survival; NA, not available; TTP, Time to progression.